SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-044314
Filing Date
2019-08-06
Accepted
2019-08-06 16:35:48
Documents
77
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-10373_110q.htm 10-Q 1615134
2 EX-31.1 a19-10373_1ex31d1.htm EX-31.1 10974
3 EX-31.2 a19-10373_1ex31d2.htm EX-31.2 10989
4 EX-32.1 a19-10373_1ex32d1.htm EX-32.1 5101
5 EX-32.2 a19-10373_1ex32d2.htm EX-32.2 5106
  Complete submission text file 0001104659-19-044314.txt   8231167

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stml-20190630.xml EX-101.INS 2223736
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20190630.xsd EX-101.SCH 58155
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20190630_cal.xml EX-101.CAL 62638
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20190630_def.xml EX-101.DEF 178635
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20190630_lab.xml EX-101.LAB 507863
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20190630_pre.xml EX-101.PRE 345508
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 191002596
SIC: 2834 Pharmaceutical Preparations